Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @myESMO
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @myESMO
-
Prikvačeni tweet
#WorldCancerDay
: 'We need to fight for and state that no limitations cannot be challenged… and create more equity in the future in the way that we treat #cancer worldwide, delivering to patients optimal cancer care'@peters_solange http://ow.ly/1Ohs50ybLwI#IAmAndIWill
pic.twitter.com/6NKO7zAQPOHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Javier Martin presenting sunitinib + nivolumab
@GrupoGeis and axitinib + pembrolizumab@SylvesterCancer for#sarcoma patients@myESMO Sarcoma#immunotherapypic.twitter.com/JPHzWyr6bB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Lee Helman discussing the potential antigens that may be used to develop cellular therapy against
#sarcoma cells. @myESMO sarcomapic.twitter.com/PNFSYPEz2E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
#MCCRWorkshop Deadline reminder TODAY 21:00 CET- Have you finalised your application to attend a week-long course designed to educate and train early-career investigators in the best practices of#clinicaltrialdesign? Apply NOW https://www.eortc.org/mccr#clinicaltrialspic.twitter.com/IpKi3zQvuw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@WHO outlines steps to save 7 million lives from#cancer. The ‘WHO Report on Cancer: setting priorities, investing wisely & providing care for all’ also mentions two ESMO resources fundamental to support accessible#cancercare & help#UHC commitment http://ow.ly/emQW50ye2Zh pic.twitter.com/3vjRjJgCAR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Systemic therapy landscape for patients with
#desmoid tumor @myESMO#Sarcomapic.twitter.com/MugEECFMi9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
General guide to estimating risk of recurrence after resection of
#GIST. Helpful in discussions regarding neoadjuvant/adjuvant imatinib. @myESMO#sarcomapic.twitter.com/bMSdN4JW1w
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
#ESMOsarcoma20@myESMO Watch out!#NTRK-fused#sarcomas also in the bones. Although more common in STS with complex genomics and WT GIST, it seems they can be found essentially across all phenotypes.pic.twitter.com/FRFrA24jK4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
...and from “his take” us as young oncologists should take motivation for moving forward research in
#sarcoma. Inspiring second day at ESMO sarcoma and GIST@myESMO@casali_pgpic.twitter.com/V0nXEQbKNK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
@SilviaStacchia : ~50% of#sarcoma are#liposarcoma ,#leiomyosarcoma, or UPS. The other subtypes are double rare @myESMOpic.twitter.com/mtVb3P52CC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
The manuscript on the global consensus about management of desmoid tumor by patients, researchers and physiscians is finally out! Thanks to all!
@DesmoidI@DTRFoundation@Fibromatosis@desmoide@sarcomapatients@ESSOnews@SocSurgOnc@myESMO@ASCO@SICOBoard@TARPSWG@SBonvalothttps://twitter.com/alegronchi/status/1224627231617617920 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Excellent meeting with
@myESMO on how to act united towards access to affordable innovative cancer medicines - I am firmly committed to people-centred cancer prevention and care across the European Region on this#WorldCancerDay
, and every day
http://bit.ly/2RVsqxr pic.twitter.com/bT7fFKXVO7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
I can’t believe it has been almost two years…
: Check out the @myESMO „Leaders Generation Programme“. For me, it has been an inspiring and truly transformative experience
https://www.esmo.org/career-development/leaders-generation-programme …pic.twitter.com/MwhxZQUExD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
World cancer day: let's fight this devastating disease. Let's improve cure rates through clinical research and by listening to our patient's needs
@myESMO@OncoAlert@JulesBordet#CancerAwareness#CancerDay2020#CancerResearchpic.twitter.com/sdo3GhHekT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#WorldCancerDay
: 'Let's get out of comfort zones and close boundaries so we can collectively assess and develop new, innovative options for #cancer patients'@RosGiuliani#IAmAndIWill
http://ow.ly/vpNQ50ycUPa pic.twitter.com/zyVzptQDxkHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
@jeanyvesblay highlighting successful#immunotherapy in#sarcoma: Our phase 2 Axi-Pembro#ASPS by @breelynwilkyMD @VaiaFlorou @drkomanduri @SylvesterCancer @myESMO Sarcoma @TheLancetOncolpic.twitter.com/zSipw6Spm2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
MPNST-like spindle cell neoplasms May have molecular aberration in NTRK or RAF. Raises therapeutic implications.
@myESMO#sarcomapic.twitter.com/wxfIWCFyhf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Very wide morphological spectrum of EWSR1 translocated cancers including but not limited to
#Sarcoma @myESMO#Sarcoma#promiscuitypic.twitter.com/fnigEQMPr7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
Frank Tirode: molecular classification of
#sarcoma begins with expert#sarcoma pathologist review. @myESMO Sarcomapic.twitter.com/j5ADvPV0K5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ESMO - Eur. Oncology proslijedio/la je Tweet
#EditorsChoice Immune-PDX mice models as a potential biomarker to support clinical decision making or to predict relapse in patients with melanoma#melsm#openaccesshttps://www.annalsofoncology.org/article/S0923-7534(19)39083-0/abstract …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.